Synthesis and binding affinity of cis-(-)- and cis-(+)-N-ethyleneamino-N-nordeoxymetazocine and cis-(-)-N-normetazocine analogues at sigma1, sigma2 and kappa opioid receptors

Eur J Pharm Sci. 2001 Jan;12(3):277-84. doi: 10.1016/s0928-0987(00)00157-3.

Abstract

The synthesis of cis-(+)- and cis-(-)-N-ethyleneamino-N-nordeoxymetazocine and cis-(-)-N-normetazocine analogues is described and their affinities to sigma1, sigma2 and kappa opioid receptors are evaluated. The cis-(+)-deoxy compounds displayed high sigma/kappa selectivity with nanomolar K(i) values for sigma1 receptors, whereas in the cis-(-)-N-normetazocine series the compound (-)-7b was found to bind with nanomolar affinity to the kappa opioid receptor (K(i)=21.5 nM). Compound (-)-7b showed good selectivity for the kappa opioid receptor in comparison to the sigma1 and sigma2 sites and to the mu and delta opioid receptors. A correlation of the binding affinities between cis-(-)- and cis-(+)-N-deoxynormetazocine derivatives show that both isomers of the deoxy analogs have similar sigma1 and sigma2 binding profiles as the cis-(+)-N-normetazocine derivatives.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Guinea Pigs
  • In Vitro Techniques
  • Indicators and Reagents
  • Male
  • Morphinans / chemical synthesis
  • Morphinans / metabolism*
  • Radioligand Assay
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Opioid, kappa / drug effects*
  • Receptors, sigma / drug effects*
  • Sigma-1 Receptor
  • Stereoisomerism

Substances

  • Indicators and Reagents
  • Morphinans
  • Receptors, Opioid, kappa
  • Receptors, sigma
  • sigma-2 receptor